Ethical Considerations of Industry-Sponsored Clinical Trials in the Arab Region-Reference-Cited by-同舟云学术

Ethical Considerations of Industry-Sponsored Clinical Trials in the Arab Region

Published:2017 Issue: Volume: Page:161-170
ISSN:2212-9529
Container-title:Research Ethics Forum
language:
Short-container-title:

Author:

Mišík Vladimír,Boleček Martin,Brady Rachel V.

Publisher

Springer International Publishing

Link

http://link.springer.com/content/pdf/10.1007/978-3-319-65266-5_14

Reference11 articles.

1. Godden, S., G. Ambler, and A.M. Pollack. 2010. Recruitment of minority ethnic groups into clinical cancer research trials to assess adherence to the principles of the Department of Health Research Governance Framework: National sources of data and general issues arising from a study in one hospital in England. Journal of Medical Ethics 36: 358–362.

2. International Federation of Pharmaceutical Manufacturers & Associations. 2014. The pharmaceutical industry and global health, facts and figures 2014. Geneva.

3. Karlberg, J.P.E. 2009. Uninterrupted globalization of industry sponsored clinical trials. Clinical Trial Magnifier 2: 79–94.

4. ———. 2010. WHO international clinical trials registry platform – an in-depth analysis. Clinical Trial Magnifier 3: 333–344.

5. ———. 2014. Globalization of industry-sponsored, clinical trials. Latest insight on shifts in sites among regions. Clinical trial magnifier, 1–36. Falls Church: FDAnews. ISBN 978–1–60428-140-8.

Cited by 1 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Patient diversity in global industry clinical trials: why it matters, who should be concerned, and what can be done?;Ethics - Scientific Research, Ethical Issues, Artificial Intelligence and Education [Working Title];2023-03-25